Health-related quality of life in patients with high-grade glioma
- PMID: 18628405
- PMCID: PMC2718958
- DOI: 10.1215/15228517-2008-050
Health-related quality of life in patients with high-grade glioma
Abstract
Health-related quality of life (HRQOL) has become an increasingly important endpoint in cancer studies; however, the research into the HRQOL of patients with high-grade glioma (HGG) is sparse compared with that for patients with other neoplasms. Owing to the specific location and poor prognosis, it is more important and difficult to study HRQOL in patients with HGG than in those with other tumors; furthermore, the study of HRQOL in patients with HGG differs from that for patients with other tumors. In this review, we identified and compared the most frequently used instruments to assess HRQOL; analyzed specific facets and determinants of HRQOL (such as sex, tumor location and histological classification, depression, and cognitive function), as well as the association between HRQOL and survival; and appraised the effects of new treatments on HRQOL in patients with HGG from randomized controlled trials. Furthermore, we detected broadly existing problems and many contradictory outcomes and gave some proper interpretation and suggestions regarding them.
Similar articles
-
Health-related quality of life of long-term high-grade glioma survivors.Neuro Oncol. 2009 Feb;11(1):51-8. doi: 10.1215/15228517-2008-049. Epub 2008 Jul 10. Neuro Oncol. 2009. PMID: 18617599 Free PMC article.
-
Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study.J Neurooncol. 2013 Oct;115(1):87-94. doi: 10.1007/s11060-013-1198-z. Epub 2013 Jul 4. J Neurooncol. 2013. PMID: 23824535
-
Health-related quality of life aspects in patients with low-grade glioma.Adv Tech Stand Neurosurg. 2010;35:213-35. doi: 10.1007/978-3-211-99481-8_8. Adv Tech Stand Neurosurg. 2010. PMID: 20102116 Review.
-
Health-related quality of life in high-grade glioma patients.Chin J Cancer. 2014 Jan;33(1):40-5. doi: 10.5732/cjc.013.10214. Chin J Cancer. 2014. PMID: 24384239 Free PMC article. Review.
-
Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life.World Neurosurg. 2017 Jun;102:383-399. doi: 10.1016/j.wneu.2017.02.061. Epub 2017 Mar 11. World Neurosurg. 2017. PMID: 28288921
Cited by
-
Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients.J Neurooncol. 2015 Sep;124(3):475-84. doi: 10.1007/s11060-015-1861-7. Epub 2015 Jul 28. J Neurooncol. 2015. Retraction in: J Neurooncol. 2017 Sep;134(2):475. doi: 10.1007/s11060-017-2592-8. PMID: 26215876 Retracted.
-
Health-related quality of life in high-grade glioma patients: a prospective single-center study.Support Care Cancer. 2012 Oct;20(10):2315-25. doi: 10.1007/s00520-011-1340-4. Epub 2011 Dec 13. Support Care Cancer. 2012. PMID: 22160582
-
Controlled rehabilitative and supportive care intervention trials in patients with high-grade gliomas and their caregivers: a systematic review.BMJ Support Palliat Care. 2016 Mar;6(1):27-34. doi: 10.1136/bmjspcare-2013-000593. Epub 2014 Jun 2. BMJ Support Palliat Care. 2016. PMID: 24890014 Free PMC article. Review.
-
Health-Related Quality of Life in Brain Tumor Patients Treated with Surgery: Preliminary Result of a Single Institution.Brain Tumor Res Treat. 2016 Oct;4(2):87-93. doi: 10.14791/btrt.2016.4.2.87. Epub 2016 Oct 31. Brain Tumor Res Treat. 2016. PMID: 27867917 Free PMC article.
-
Controversies concerning the application of brachytherapy in central nervous system tumors.J Cancer Res Clin Oncol. 2010 Feb;136(2):173-85. doi: 10.1007/s00432-009-0741-y. J Cancer Res Clin Oncol. 2010. PMID: 19956971 Review.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Buckner JC, Brown PD, O’Neill BP, Meyer FB, Wetmore CJ, Uhm JH. Central nervous system tumors. Mayo Clin Proc. 2007;82:1271–1286. - PubMed
-
- Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835–840. - PubMed
-
- Macdonald DR, Kiebert G, Prados M, Yung A, Olson J. Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life. Cancer Invest. 2005;23:138–144. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical